id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-D-0233-0031,FDA,FDA-2008-D-0233,"Reference 1 - ""Biggerstaff, B.J., et al., Estimated Risk of West Nile Virus Transmission Through Blood Transfusion During an Epidemic in Queens, New York City."" Transfusion 2002; 42:1019-1026 (2002)."" [FDA-2008-D-0233-0030]",Supporting & Related Material,REF-Reference (internal unless indicated),2009-11-10T05:00:00Z,2009,11,,,2009-11-10T15:01:56Z,,0,0,0900006480a5473e
FDA-2008-D-0233-0029,FDA,FDA-2008-D-0233,Guidance for Industry: Use of Nucleic Acid Tests to Reduce the Risk of Transmission of West Nile Virus from Donors of Whole Blood and Blood Components Intended for Transfusion; Availability,Notice,NAD-Notice of Availability of Data,2009-11-09T05:00:00Z,2009,11,2009-11-09T05:00:00Z,,2009-11-09T17:00:09Z,E9-26870,0,0,0900006480a53fe0
FDA-2008-D-0233-0030,FDA,FDA-2008-D-0233,Guidance for Industry: Use of Nucleic Acid Tests to Reduce the Risk of Transmission of West Nile Virus from Donors of Whole Blood and Blood Components Intended for Transfusion - Guidance,Other,GDL-Guidance (Supporting and Related Materials),2009-11-09T05:00:00Z,2009,11,2009-11-09T05:00:00Z,,2024-11-07T22:09:30Z,,1,0,0900006480a5461c
FDA-2008-D-0233-0026,FDA,FDA-2008-D-0233,"Reference 5 - ""Blood Products Advisory Committee, 89th Meeting, April 27, 2007"" - [re FDA-2008-D-0233-0002]",Supporting & Related Material,SUP-Supplement (Supporting and Related Material),2009-05-12T04:00:00Z,2009,5,,,2009-05-13T03:17:35Z,,0,0,090000648098b86c
FDA-2008-D-0233-0027,FDA,FDA-2008-D-0233,"Reference 10 - ""MMWR 2004 Centers for Disease Control and Prevention - Transfusion-Associated Transmission of West Nile Virus - Arizona, 2004"" - [re FDA-2008-D-0233-0002]",Supporting & Related Material,SUP-Supplement (Supporting and Related Material),2009-05-12T04:00:00Z,2009,5,,,2009-05-12T22:46:08Z,,0,0,090000648098ba29
FDA-2008-D-0233-0025,FDA,FDA-2008-D-0233,"Reference 1 - ""Food and Drug Administration, Guidance for Industry: Eligibility Determiniation for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps), August 2007  - [re FDA-2008-D-0233-0002]",Supporting & Related Material,SUP-Supplement (Supporting and Related Material),2009-05-12T04:00:00Z,2009,5,,,2009-05-12T22:46:05Z,,0,0,090000648098b73d
FDA-2008-D-0233-0028,FDA,FDA-2008-D-0233,"Reference 11 - ""MMWR 2007 Centers for Disease Control and Prevention - West Nile Virus Transmission - South Dakato, 2006"" - [re FDA-2008-D-0233-0002]",Supporting & Related Material,SUP-Supplement (Supporting and Related Material),2009-05-12T04:00:00Z,2009,5,,,2009-05-12T22:46:09Z,,0,0,090000648098bc07
FDA-2008-D-0233-0024,FDA,FDA-2008-D-0233,"Use of Nucleic Acid Tests to Reduce the Risk of Transmission of West Nile Virus from Donors of Whole Blood and Blood Components Intended for Transfusion and Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) - Reference List (1-13) - [re FDA-2008-D-0233-0002]",Supporting & Related Material,REF-Reference (internal unless indicated),2009-05-12T04:00:00Z,2009,5,,,2009-05-12T22:46:04Z,,0,0,090000648098b73b
FDA-2008-D-0233-0003,FDA,FDA-2008-D-0233,"Draft Guidance for Industry: Use of Nucleic Acid Tests to Reduce the Risk of Transmission of West Nile Virus From Donors of Whole Blood and Blood Components Intended for Transfusion and Donors of Cells, Tissues, and Cellular and Tissue-Based Products; Request for Data",Notice,"NRD-Notice of Requesting Data, Info, & Views",2008-07-07T04:00:00Z,2008,7,2008-07-07T04:00:00Z,,2008-07-07T11:57:02Z,E8-15368,0,0,090000648065a4ee
FDA-2008-D-0233-0002,FDA,FDA-2008-D-0233,"Guidance for Industry: Use of Nucleic Acid Tests to Reduce the Risk of Transmission of West Nile Virus from Donors of Whole Blood and Blood Components Intended for Transfusion and Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) - Draft Guidance",Other,GDL-Guidance (Supporting and Related Materials),2008-04-28T04:00:00Z,2008,4,2008-04-28T13:08:29Z,,2024-11-12T04:14:16Z,,1,0,0900006480538137
FDA-2008-D-0233-0001,FDA,FDA-2008-D-0233,"Draft Guidance for Industry: Use of Nucleic Acid Tests to Reduce the Risk of Transmission of West Nile Virus from Donors of Whole Blood and Blood Components Intended for Transfusion and Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps); Availability",Notice,NAD-Notice of Availability of Data,2008-04-28T04:00:00Z,2008,4,2008-04-28T04:00:00Z,2008-07-29T03:59:59Z,2024-11-12T04:13:44Z,E8-09253,1,0,0900006480537ea6